ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 67 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $1,603,000 | -33.8% | 712,651 | 0.0% | 0.00% | – |
Q3 2017 | $2,423,000 | -4.2% | 712,651 | 0.0% | 0.00% | – |
Q2 2017 | $2,530,000 | +4.4% | 712,651 | 0.0% | 0.00% | – |
Q1 2017 | $2,423,000 | -26.1% | 712,651 | 0.0% | 0.00% | – |
Q4 2016 | $3,278,000 | -1.4% | 712,651 | -9.1% | 0.00% | – |
Q3 2016 | $3,325,000 | +76.7% | 784,091 | 0.0% | 0.00% | – |
Q2 2016 | $1,882,000 | -56.4% | 784,091 | -14.6% | 0.00% | -100.0% |
Q1 2016 | $4,316,000 | +13.0% | 918,325 | -5.5% | 0.00% | 0.0% |
Q4 2015 | $3,821,000 | +1.6% | 972,165 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $3,762,000 | -16.9% | 972,165 | -1.2% | 0.00% | 0.0% |
Q2 2015 | $4,525,000 | -31.6% | 983,665 | +0.3% | 0.00% | 0.0% |
Q1 2015 | $6,611,000 | +108.7% | 980,865 | 0.0% | 0.00% | – |
Q4 2014 | $3,168,000 | – | 980,865 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
IFP Advisors, Inc | 0 | $0 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |